ZURICH/LONDON (Reuters) - Swiss drugmaker Roche Holding AG has offered $5.7 billion in cash in a hostile bid to take over Illumina Inc , and investors are already betting that the U.S. gene sequencing ...
ZURICH (Reuters) - Roche extended its $5.7 billion (3.5 billion pound) hostile cash bid for U.S. gene decoder Illumina on Monday, showing the Swiss drugmaker's willingness to play a waiting game, an M ...
Backed by a $15 million Series A financing, NextCODE Health in Massachusetts is now officially open for business. The new Cambridge startup is built around crucial gene sequencing technology developed ...
With its collaborators Genentech, Icelandic company DeCode Genetics has found a rare gene variant that marks protection against both Alzheimer's disease and general cognitive decline. This discovery ...
The human brain may be the most complex piece of organized matter in the known universe, but researchers have begun to unravel the genetic code underlying its function. Research has now identified a ...